Results 201 to 210 of about 263,791 (359)

A Current Perspective on the Assessment of Prevalence of Dengue Cases in a Territory Care Hospital Bangalore and Impact of Clinical Pharmacist Mediated Patient Counseling – A Prospective Study

, 1970
Muchukota Sushma, L Bhoomika, M C Dinesh, V. Yadav, C Kavana., Rinku Mathappan   +5 more
openalex   +2 more sources

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Implementation evaluation of a pharmacist prescribing service for the management of dermatological conditions: a study protocol. [PDF]

BMC Health Serv Res
Amador-Fernandez N, Benrimoj SI, Martinez-Mardones F, Diamandis S, Moullin JC, Schierhout G, Heenan M, Dineen-Griffin S.   +7 more
europepmc   +1 more source

The community pharmacist: health sentinel on the home front.

, 1974
P Gervasi
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. [PDF]

Tob Use Insights
Halliday DM, Schneider S, Wakefield T, Durazo A, Tracy D, Song AV, Apollonio DE.   +6 more
europepmc   +1 more source

Wound care and the pharmacist [PDF]

, 1993
D.A.L. Morgan
openalex   +1 more source

Good Medicine: Why Pharmacists Should Be Prescribed a Right of Conscience [PDF]

, 2010
Duffy, Michael E.
core   +2 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Impact of clinical pharmacy services on patient outcomes in Sudan: a systematic review of interventional studies. [PDF]

BMC Health Serv Res
Hamadalneel YB, Badi S, Elmadani M, Ahmed KO, Omer AAA.   +4 more
europepmc   +1 more source